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ABSTRACT: IFN-γ activation of mononuclear phagocytes significantly increases indoleamine 2,3-dioxygenase (IDO) and flux through the
kynurenine pathway (KP). However, the effect of IDO on NAD+ synthesis, the end product of KP metabolism, is unknown. To investigate this,
primary human peripheral blood mononuclear cells were cultured up to 10 days and activated with IFN-γ in the presence or absence of a
poly(ADP-ribose) polymerase (PARP) inhibitor. Day 10 macrophages had significantly higher NAD+ levels compared with monocytes. IFN-γ
activation of macrophages resulted in the highest induction of IDO but decreased intracellular NAD+ concentrations at both 24 and 48 hours.
However, IFN-γ activation of both day 6 and day 10 macrophages in the presence of a PARP inhibitor resulted in significantly higher intracellular
NAD+ levels at 24 hours. This study provides evidence for the first time that an immune-mediated increase in IDO activity increases NAD+
biosynthesis concomitantly with an increase in NAD+ catabolism in primary human macrophages.
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Introduction

Mononuclear phagocytes (ie, monocyte/macrophages) are an
important part of the bodies’ phagocytic and cell defence system and are found in virtually all tissues of the body with large
numbers in the lymphoid organs, the liver, lungs, and digestive
tract.1 These cells, influenced by the microenvironment, mount
specific defence processes. Circulating monocytes will differentiate into tissue macrophages which can be broadly classified in
2 groups: M1 macrophages, following activation by IFN-γ or
lipopolysaccharides (LPS) or M2-activated macrophages
which are further subdivided in M2a (stimulated by interleukin
4 [IL]-4 or IL-13), M2b (immune complexes in combination
with IL-1β or LPS), and M2c (IL-10, transforming growth
factor β or glucocorticoids).2 Activation of macrophages with
IFN-γ, tumour necrosis factor α and IL-1β significantly
upregulates the first and rate-limiting enzyme of the kynurenine pathway (KP), indoleamine 2,3-dioxygenase (IDO). The
reasons for why the inflammatory response increases IDO activation, and subsequent increased flux through the KP, are not
fully understood. Although previous research has shown a role
for reducing foetal tissue rejection in allogeneic pregnancy3 and
certain upstream KP metabolites have antimicrobial activity,
the reasons for its increase in downstream KP metabolism during normal macrophage activation is still unknown.
Previous research using the murine monocyte/macrophage
cell line RAW264.74 and human astroglial cell line HTB-1385
suggest a link between the IFN-γ–mediated actions of increased
free radical synthesis and IDO induction. However, these
immortalised cell lines are physiologically different from the

nontransformed cells. Being essentially phenotypically stable,
these cells do not undergo differentiation (ie, maturation),
although they can be activated by an appropriate stimulus such
as IFN-γ. Nontransformed mononuclear phagocytes, however,
can undergo both differentiation and activation.
After migrating from the bloodstream, monocytes undergo
irreversible maturation (differentiation) into macrophages and
tissue-specific cells. The process of proliferation and differentiation is mediated by a variety of specific glycoproteins including
colony-stimulating factor (CSF-1), granulocyte-macrophage colony-stimulating factor, IL-3, and others.1 Adhesion to the vascular endothelium is also an early signal for monocyte differentiation
in vivo.6 In a similar way, adherence to the synthetic substratum of
a tissue culture dish in vitro has also been shown to facilitate the
differentiation of isolated monocytes into mature macrophages.7
As the potential for localised DNA damage and subsequent
poly(ADP-ribose) polymerase (PARP) activation, NAD
depletion is high in mononuclear phagocytic cells following
IFN-γ activation.8 The aim of this study was to investigate the
effect of IFN-γ treatment on intracellular NAD concentration
and IDO activity in human peripheral blood mononuclear cells
at different stages of differentiation.

Materials and Methods
Materials
RPMI 1640 was purchased from Life Technologies (Sydney,
Australia). 3-Aminobenzamide (3ABA), phenazine methosulfate,
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alcohol dehydrogenase (baker’s yeast), bicine, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide, catalase (3200 U/
mg solid, bovine liver), tryptophan, and p-dimethylamino-benzaldehyde (Ehrlich reagent) were purchased from Sigma-Aldrich
(Sydney, Australia). Human recombinant IFN-γ was purchased
from Australian Laboratory Services (Sydney, Australia). Bovine
calf serum was purchased from Commonwealth Serum
Laboratories (Sydney, Australia).

Monocyte isolation
Human peripheral blood monocytes were extracted from
400 mL of whole blood from healthy human immunodeficiency
virus 1–seronegative volunteers as described by Kazazi et al.9
Briefly, blood mononuclear cells were obtained by differential
centrifugation in Ficoll-Hypaque (Pharmacia-AMRAD,
Sydney, Australia). Monocytes were separated from other mononuclear cells by counter-current elutriation (Beckman centrifuge J-6M/E fitted with a JE-5.0 Elutriation Rotor; Beckman
Coulter, Sydney, Australia) followed by plastic adherence. Cells
were plated at a density of 7 × 105 cells/mL of medium which
consisted of RPMI 1640 supplemented with 10% heat-inactivated foetal bovine serum, 10% heat-inactivated pooled AB+
human serum, and 50 μM tryptophan (RF10/10) in a 48-well
tissue culture plate (Nunc, Sydney, Australia). Cells were then
placed immediately in a 37°C incubator in a humidified atmosphere of 5% CO2.

NAD analysis
The cellular pyridine nucleotide content (NAD+ + NADH)
was measured by the Thiazolyl blue microcycling assay of
Bernofsky and Swan adapted to 96-well plate format.10

Quinolinic acid assay
Quinolinic acid (QUIN) was measured by gas chromatography-electron capture ion mass spectrometry as described
previously.11

IDO activity
The IDO activity was determined in the cell homogenate by a
slight modification of the method of Hara et al.12 Briefly,
100 μL of 30% trichloroacetic acid (TCA) was added to 200 μL
of the culture supernatant, vortexed, and then spun at
10 000 rpm for 5 minutes. About 125 μL of the supernatant was
added to 125 μL of Ehrlich reagent (100 mg/5 mL glacial acetic acid) in a microtitre plate well (96-well format). Samples
were read against a reagent blank with a 492-nm filter in a
Multiskan MS (Labsystems, Vantaa, Finland) microplate
reader. The change in kynurenine concentration was obtained
by subtracting the kynurenine content of fresh uncultured
media from the value derived from the cultured supernatant.
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The kynurenine concentration of samples containing 3ABA,
which produces spectral interference with the Takikawa method
(unpublished observations), was obtained using high-performance liquid chromatography (HPLC). Briefly, samples for
HPLC analysis were prepared by precipitating the protein in
200 μL of sample with 100 μL of 30% TCA. The sample was
then centrifuged at 15 000 rpm for 5 minutes. About 50 μL of the
resultant supernatant was injected onto a C18 reverse-phase column (250 mm × 6 mm). The mobile phase was ammonium acetate buffer (0.1 M, pH 4.65) with 4% acetonitrile. Flow rate was
0.6 mL/min (GBC LC1150 HPLC pump). Sample was detected
by UV at 365 nM using a (GBC LC1250 UV/VIS detector).

Experimental procedure
A total of 700 000 freshly elutriated cells were seeded into each
well of a 24-well culture plate containing 1 mL of culture
media. IFN-γ (500-600 U/mL) and/or the PARP inhibitor
3ABA (≥5 mM) was then added to selected wells for 24 or
48 hours on days 0, 6, and 10 in culture; cells were equilibrated
for ~30 minutes at 37°C in 5% CO2 before the addition of
3ABA and/or IFN-γ (Figure 1). At the end of the experimental
period, the supernatants were aspirated and stored at −80°C
until analysis for QUIN. Intracellular NAD concentration and
IDO activity were performed as soon as possible on the sonicated whole-cell homogenate, stored at −80°C immediately
following the experimental period. Remaining cell cultures
were fed with fresh medium every 3 or 4 days.

Statistical analysis
Results are expressed as the mean ± SEM. Significant differences between treatment groups was determined using the
2-tailed t test or, where indicated, analysis of variance with the
post hoc Tukey-Kramer multiple comparisons test. Differences
between treatment groups was considered significant if P < .05.

Results
Effect of IFN-γ concentration and exposure time on
IDO activity in monocytes and macrophages
In this study, we investigated the effect of exposing human
mononuclear phagocytes at different stages of maturation to
increasing concentrations of IFN-γ for 24 and 48 hours.
Figure 2 shows that the IFN-γ–mediated increase in IDO
activity is dependent on both the concentration of IFN-γ, where
a maximum response is reached at 100 U/mL, and the time in
culture, which corresponds to the level of cell differentiation.
This same pattern of ‘cell differentiation and exposure time’
dependent increase in IDO activity was observed for multiple
donors (Figure 3), where the IDO activity from cells by day 6 in
culture exposed to IFN-γ (600 U/mL) for 24 or 48 hours was not
significantly different from the respective IDO activities measured
for IFN-γ–treated (24 or 48 hours) day 10 macrophages (Figure 3).
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Figure 1. Experimental procedure. Human peripheral blood monocytes were maintained in culture for up to 12 days. Cells at different stages of cell
maturation (differentiation) were treated with IFN-γ and/or 3ABA for 24 or 48 hours before analysis of intracellular NAD and IDO and selected tryptophan
metabolites in the supernatant. 3ABA indicates 3-aminobenzamide; IDO, indoleamine 2,3-dioxygenase.

Figure 2. Maturation-dependent increase in IDO activity in IFN-γ–activated human monocyte/macrophages from a single donor. Human mononuclear
phagocytic cells from a single donor cultured for 0 or 10 days were exposed to IFN-γ at a final concentration of 10, 100, or 600 U/mL for either 24 or
48 hours. IDO activity was determined on the cell homogenate. A dose- (IFN-γ), time-, and maturation-dependent increase in IDO activity was observed.
*P < .05; **P < .01; ***P < .001 (n = 4-12). Statistics used was the Tukey-Kramer analysis of variance. IDO indicates indoleamine 2,3-dioxygenase.

One incongruent result for day 0 monocytes (48-hour
IFN-γ treatment) from one donor was not included in Figure
3. These monocytes produced a very high IDO activity
(57 ± 2 nmol kynurenine/90 min/well, n = 11) compared with
the mean activity of other donors cells (12 ± 2 nmol kynurenine/90 min/well, n = 15), whereas IFN-γ activation of day 10
macrophages from this same donor produced an IDO activity

within the normal range (~30 nmol kynurenine/90 min/well)
(see Figure 2).

Effect of cell maturation on intracellular NAD
concentration
The intracellular NAD concentration of untreated cells
increased significantly as cells matured (ie, differentiated)
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Figure 3. Average, maturation-dependent increase in IDO activity in IFN-γ–activated monocyte/macrophages from multiple donors. Human mononuclear
phagocytic cells from multiple donors were cultured for 0, 6, or 10 days, then either left untreated (C) or treated with IFN-γ (600 U/mL) for 24 or 48 hours.
IDO activity was determined on the cell homogenate. ‘A statistically significant time-dependent (24-48 hours) increase in IDO activity was observed for
day 0 and day 10 cultures’. The response to IFN-γ–induced IDO activity was significantly greater in macrophages (day 10) compared with monocytes (day
0). *P < .001; **P < .05; ***P < .001 compared with IFN-γ day 0, 48 hours (n = 7-24) separate cultures from 4 different donors. Statistics used was the
Tukey-Kramer analysis of variance. IDO indicates indoleamine 2,3-dioxygenase.

NAD in cultures at all stages of differentiation (days 0-6,
Figure 5A to C). Coadministration of IFN-γ with 3ABA for
24 hours resulted in a significant increase in cellular NAD levels above treatment with 3ABA alone in both day 6 and day 10
cultures (Figure 5B and C).

Effect of IFN-γ on QUIN production in monocytes
and macrophages

Figure 4. Intracellular NAD concentrations increase in unstimulated
human monocyte/macrophages with the degree of differentiation. Human
monocyte/macrophages from a single donor were cultured from 1 to
12 days. Intracellular NAD concentration was determined on the cell
homogenate. Cellular NAD concentration increased significantly with time
corresponding with the stage of cell differentiation from monocyte to
macrophage. *P < .01; **P < .05 (n = 3-8).

from monocytes at day 0 to macrophages by day 10 in culture
(Figure 4).

Effect of IFN-γ in the absence and presence of
a PARP inhibitor on monocytes and monocytederived macrophages
After 0, 6, or 10 days in culture, human recombinant IFN-γ
(600 U/mL) ± the PARP inhibitor (3ABA) was added to
selected wells for either 24 or 48 hours. Cells were then sonicated and assayed for NAD concentration in the cell homogenate. Exposure to IFN-γ for 24 hours decreased intracellular

Supernatant from selected cultures was analysed for QUIN,
the final KP intermediate before phosphoribosylation.
Quinolinic acid concentrations were significantly increased
in the culture supernatant after exposure to IFN-γ for 48 hours
in both monocytes and macrophages. Quinolinic acid production from macrophages was significantly greater than for
undifferentiated monocytes (Figure 6).

Effect of 3ABA on IDO activity and supernatant
kynurenine and QUIN concentration in monocytes
and macrophages
The PARP inhibitor 3ABA was used throughout this study
as an effective inhibitor of the NAD catabolic enzyme PARP.
We sought to determine whether 3ABA had any non-specific
effects on the activity of the KP in either IFN-γ–activated or
untreated control day 10 macrophages. Figure 7 shows that
both IDO activity and supernatant kynurenine concentration
were marginally reduced in IFN-γ–activated macrophages
treated with 3ABA. Quinolinic acid levels in the supernatant
were reduced following 3ABA treatment in unactivated macrophages. Although the absolute value for QUIN
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Figure 6. Effect of IFN-γ on quinolinic acid production in human
monocyte/macrophages. Human monocyte/macrophage cells from 3
different donors were cultured for either 0 or 10 days and then either left
untreated (C) or treated with IFN-γ (600 U/mL) for 48 hours. Quinolinic
acid concentration was determined in the culture supernatant. *P < .0001
compared with (C) day 0; **P < .0001 compared with (C) day 10;
***P < .0001 compared with IFN-γ day 0 (n = 4-7).

monocyte-derived macrophages (MDM) at 3 stages of
differentiation:
1. Undifferentiated (fresh monocytes);
2. Partially differentiated (after day 6 in culture);
3. Fully differentiated (day 10 in culture) MDMs.

Monocyte to macrophage differentiation

Figure 5. Effect of IFN-γ and 3ABA on intracellular NAD concentration in
monocytes (A): 6-day-old MDM and 10-day-old MDM. Human MDMs
from 4 different donors were cultured for the times indicated and then
either left untreated (C) or treated with IFN-γ (600 U/mL) and/or 3ABA
(≥5 mM) for 24 or 48 hours. NAD concentration was determined on the
cell homogenate. (A) *P < .01; **P < .05; ***P < .001 (n = 3-23). (B) *P < .001;
**P < .05 (n = 3-10). (C) *P < .05; **P < .01 (n = 8-19). Statistics used was the
Tukey-Kramer analysis of variance. 3ABA indicates 3-aminobenzamide;
MDMs, monocyte-derived macrophages.

concentration was lower in activated macrophage cultures in
the presence of 3ABA, this did not reach statistical significance (Figure 7).

Discussion

Various KP metabolites have been detected in the extracellular
fluid of immune-activated cells.13,14 However, the relationship
between increased oxidative tryptophan catabolism and de
novo NAD synthesis has not been investigated.
Although previous studies using a macrophage cell line15
strongly suggest an increase in NAD synthesis and catabolism
following IDO induction by IFN-γ, a repeat of these studies
was needed in nontransformed primary cells.
The effect of IFN-γ on IDO induction and intracellular
NAD concentration was investigated in human

Mononuclear phagocytes play an important role in host cell–
mediated immunity. Undifferentiated monocytes are released
continually into the bloodstream from the bone marrow. These
cells then migrate to the viscera where local factors initiate the
process of differentiation into specialised resident macrophages.
During inflammation, the release of chemotactic cytokines
increases the migration of monocytes to the site of injury. These
infiltrating monocytes along with the resident macrophages are
then activated by soluble factors, in particular, IFN-γ.16
In this study, it was found that KP metabolism was increased
to a much greater extent in differentiated compared with
undifferentiated cells in response to IFN-γ, as determined by
IDO activity, kynurenine, QUIN, and NAD assays.

IDO induction by IFN-γ in MDMs
Consistent with previous reports, IFN-γ effectively increased
IDO activity in these cultured monocyte/macrophages14 at all
stages of differentiation in a dose-dependent fashion (Figures 2
and 3).
In this study, we found that, in agreement with previous
investigations,17 exposure to the same concentration of IFN-γ
produced a much greater increase in IDO activity in differentiated macrophages compared with undifferentiated monocytes
(Figure 2 & 3). This is consistent with an overall greater metabolic activity and response to immune modulators in macrophages compared with monocytes.
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relatively small percentage of degraded tryptophan is secreted as
QUIN under these conditions. The reason for this is not clear.
Kynurenine can be converted to at least 2 other metabolites
besides 3-hydroxykynurenine, kynurenic acid, and anthranilic
acid. Although MDMs do not appear to secrete kynurenic
acid15 unless stimulated by TLR-3,18 the kynurenine excreted
by these cells may be taken up by other cells within the vicinity
of the inflammation site and used for either de novo production
of NAD or synthesis of either/or both of these 2 alternative
compounds.
Interestingly, the mild inhibitory effect of 3ABA on IDO
did not significantly affect the level of QUIN secretion indicating that kynurenine production at maximum activation may be
saturating downstream enzymes with substrate.
A more extensive investigation using coculture techniques is
needed to provide further insight into the fate of kynurenine
under these conditions.

Effect of IFN-γ activation, in the presence
or absence of 3ABA, at different stages of cell
differentiation on intracellular NAD concentration

Figure 7. The effect of 3ABA on kynurenine pathway metabolism:
10-day-old macrophages were either left untreated or treated with 3ABA
or IFN-γ or 3ABA + IFN-γ. After 48 hours, samples were taken and
analysed for (A) IDO activity, determined from the cell homogenate.
Results are presented as a percentage of untreated control cultures (C),
*P < .005 (n = 5-6) compared with IFN-γ. (B) Kynurenine concentration in
the culture supernatant, *P < .05 (n = 5-6) compared with IFN-γ. (C)
Quinolinic acid concentration in the culture supernatant, *P < .001 (n = 5-6)
compared with control (C). 3ABA indicates 3-aminobenzamide; IDO,
indoleamine 2,3-dioxygenase.

Effect of IFN-γ activation at different stages of cell
differentiation on QUIN production
Consistent with the pattern shown for IDO activity
(Figures 2 and 3), QUIN production was much greater in
IFN-γ–activated macrophages compared with monocytes
(Figure 6).
This demonstrates an increased flux through this pathway
at least as far as QUIN under these conditions.
Quinolinic acid concentration in the extracellular fluid, however, was approximately an order of magnitude lower than that
for kynurenine (Figure 7B and C), indicating that only a

The intracellular NAD concentration in unactivated cells
increased with the amount of time spent in culture. This corresponded to the level of cell differentiation from monocyte
(lowest NAD content) to macrophage (highest NAD content)
(Figure 4).
This is consistent with the increase in morphological size,
and we assume metabolic requirements, of the cell in direct
relation to the degree of differentiation.
Following 24-hour treatment with 3ABA (PARP inhibition), intracellular NAD increased in unactivated cells at days 6
and 10 but not day 0 (Figure 5A to C), suggesting that NAD
catabolism due to PARP activity increases as a consequence of
in vitro cell differentiation.
It has been known for some time that activation of human
MDM with IFN-γ also increases PARP activity.19 Following
IFN-γ activation, intracellular NAD concentration decreased
significantly in cells at all 3 stages of differentiation (Figure 5A
to C), indicating that the catabolism of NAD in these activated
cells was greater than its synthesis.
NAD levels, however, in these IFN-γ–activated cells in the
presence of the PARP inhibitor, 3ABA, was either retained
(Figure 5A) or significantly increased (Figure 5B and C).
Increased de novo synthesis of NAD in undifferentiated cells
(day 0) is not expected as induction of IDO by IFN-γ in
monocytes is negligible at 24 hours (Figure 2). The significant
increase in NAD levels after activation and PARP inhibition
on days 6 and 10 (Figure 5B and C), however, appears to
reflect the corresponding significant increase in IDO activity
(Figure 3).
Although 24-hour exposure to IFN-γ in the presence of a
PARP inhibitor resulted in a significant increase in cellular
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NAD coinciding with increased IDO activity, 48-hour exposure to IFN-γ and 3ABA did not reproduce this result (Figure
5A and C). The reasons for this are not clear. Figure 7 shows
that treatment with 3ABA for 48 hours reduces both IDO
activity and supernatant kynurenine concentration in IFN-γ–
activated cells, whereas QUIN levels were marginally reduced
in 3ABA-treated unactivated cells only. This suggests that
exposure to 3ABA for longer periods may reduce flux through
the KP to some degree. However, as the production of the
immediate NAD precursor QUIN was not significantly
reduced, NAD synthesis may not be affected. It is possible,
though, that longer term activation of these cells (ie, 48 hours)
may result in either an accumulation of cytotoxic products in
the static culture medium or a decrease in essential metabolic
cofactors, both of which may affect enzyme involved in the
synthesis of NAD.
Conversion of QUIN into NAD requires cofactors, such as
phosphoribosyl pyrophosphate, adenosine triphosphate, and
glutamine, any of which may become depleted over time and
thereby rate limiting in the synthesis of NAD. Further studies
are required to test this hypothesis. In addition, it has been suggested by others that expression of the NAD synthetic enzyme
quinolinate phosphoribosyl transferase in macrophages may be
dependent on specific stimulatory signals20 which may be disrupted in the presence of 3ABA.

Conclusions

In conclusion, this study using human MDMs has provided
evidence which indicates that an immune-mediated increase in
IDO activity does increase NAD biosynthesis concomitantly
with an increase in NAD catabolism. This phenomenon was
clearly observed in differentiated cells after 24-hour exposure
to maximal activating doses of IFN-γ but was less obvious after
48 hours.
These results are consistent with data from a previous study
using the RAW264.7 monocyte/macrophage cell line.15
However, the process of NAD synthesis in the human primary
cells following IDO induction by IFN-γ appears to be affected
by the degree of cell differentiation at the time of immune
activation.
These results do support a role for IDO induction in
increased NAD synthesis which may provide substrate for continuing PARP activity facilitating nuclear repair and hence
long-term cell (ie, monocyte/macrophage) viability. As inhibitors for IDO have been developed for potential clinical use in
inflammatory-associated conditions,21 recognition of the role
of IDO induction and its role in maintaining NAD+ levels in
front-line immune cells may be relevant to developing final
effective treatment regimens.
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